The Global Surrogacy Market was valued at USD 22.4 billion in 2024 and is estimated to grow at a CAGR of 24.6% to reach USD 201.8 billion by 2034. Surrogacy brings together a range of medical services and reproductive technologies that allow individuals or couples to build a family through a surrogate. This expanding space covers the involvement of fertility clinics, hospitals, and a growing network of reproductive healthcare providers worldwide. As modern societal norms shift and healthcare infrastructure continues to evolve, surrogacy is gaining traction as a viable and widely accepted family-building option.
Across the globe, rising infertility rates remain one of the primary drivers of this market. Factors like high-stress lifestyles, environmental toxins, obesity, delayed pregnancies, and various medical conditions are increasing infertility among men and women. As these challenges grow more common, more people are turning to assisted reproductive technologies (ART) like surrogacy to realize their dream of parenthood. Technological progress in fertility treatment, paired with greater public awareness, is making it easier for people to consider and access services related to surrogacy. Enhanced education on reproductive health and growing support from advocacy groups are also encouraging individuals to explore non-traditional pathways to parenthood. This trend is particularly evident among single parents and same-sex couples, who are becoming a significant part of the consumer base in the surrogacy ecosystem.
Gestational surrogacy accounted for USD 21.4 billion in 2024 and continues to see strong demand. This segment is growing rapidly, especially in regions where supportive legal frameworks exist. Countries with defined laws and medical guidelines for gestational surrogacy, such as those in North America, are witnessing higher adoption rates. Legal protections for both surrogates and intended parents, including rights, medical access, and insurance coverage, are creating a more secure and appealing environment for those entering into surrogacy arrangements.
In-vitro fertilization (IVF) held a dominant 63.4% share in 2024 and remains the most trusted method in the surrogacy process. IVF plays a critical role for individuals with age-related infertility, health complications, or those in same-sex relationships aiming to have biological children. Its high success rate and technological advancements make IVF the go-to choice for intended parents seeking reliable outcomes.
The U.S. Surrogacy Market generated USD 5.1 billion in 2024, driven by rising infertility cases and increased demand for IVF-based surrogacy. The country’s advanced medical infrastructure, legal clarity, and broad acceptance of reproductive technologies have made surrogacy a mainstream choice.
Key players in the global surrogacy space include Kindbody, Circle Surrogacy, Boston IVF, NOVA IVF, Ovation Fertility, Max Healthcare, Growing Generations, Bourn Hall International, New Hope Fertility Clinic, Houston Fertility Center, Scanfert Clinic, Extraordinary Conceptions, IVIRMA, MLSPL, and Bangkok IVF Center. These companies are enhancing their global presence, adopting cutting-edge ART solutions, and designing personalized treatment plans. Strategic collaborations with insurers and continued advocacy for inclusive surrogacy laws are central to expanding access and building trust among intended parents.
This product will be delivered within 2-4 business days.
Across the globe, rising infertility rates remain one of the primary drivers of this market. Factors like high-stress lifestyles, environmental toxins, obesity, delayed pregnancies, and various medical conditions are increasing infertility among men and women. As these challenges grow more common, more people are turning to assisted reproductive technologies (ART) like surrogacy to realize their dream of parenthood. Technological progress in fertility treatment, paired with greater public awareness, is making it easier for people to consider and access services related to surrogacy. Enhanced education on reproductive health and growing support from advocacy groups are also encouraging individuals to explore non-traditional pathways to parenthood. This trend is particularly evident among single parents and same-sex couples, who are becoming a significant part of the consumer base in the surrogacy ecosystem.
Gestational surrogacy accounted for USD 21.4 billion in 2024 and continues to see strong demand. This segment is growing rapidly, especially in regions where supportive legal frameworks exist. Countries with defined laws and medical guidelines for gestational surrogacy, such as those in North America, are witnessing higher adoption rates. Legal protections for both surrogates and intended parents, including rights, medical access, and insurance coverage, are creating a more secure and appealing environment for those entering into surrogacy arrangements.
In-vitro fertilization (IVF) held a dominant 63.4% share in 2024 and remains the most trusted method in the surrogacy process. IVF plays a critical role for individuals with age-related infertility, health complications, or those in same-sex relationships aiming to have biological children. Its high success rate and technological advancements make IVF the go-to choice for intended parents seeking reliable outcomes.
The U.S. Surrogacy Market generated USD 5.1 billion in 2024, driven by rising infertility cases and increased demand for IVF-based surrogacy. The country’s advanced medical infrastructure, legal clarity, and broad acceptance of reproductive technologies have made surrogacy a mainstream choice.
Key players in the global surrogacy space include Kindbody, Circle Surrogacy, Boston IVF, NOVA IVF, Ovation Fertility, Max Healthcare, Growing Generations, Bourn Hall International, New Hope Fertility Clinic, Houston Fertility Center, Scanfert Clinic, Extraordinary Conceptions, IVIRMA, MLSPL, and Bangkok IVF Center. These companies are enhancing their global presence, adopting cutting-edge ART solutions, and designing personalized treatment plans. Strategic collaborations with insurers and continued advocacy for inclusive surrogacy laws are central to expanding access and building trust among intended parents.
Comprehensive Market Analysis and Forecast
- Industry trends, key growth drivers, challenges, future opportunities, and regulatory landscape
- Competitive landscape with Porter’s Five Forces and PESTEL analysis
- Market size, segmentation, and regional forecasts
- In-depth company profiles, business strategies, financial insights, and SWOT analysis
This product will be delivered within 2-4 business days.
Table of Contents
Chapter 1 Methodology and Scope
Chapter 2 Executive Summary
Chapter 3 Industry Insights
Chapter 4 Competitive Landscape, 2024
Chapter 5 Market Estimates and Forecast, by Type, 2021-2034 ($ Mn)
Chapter 6 Market Estimates and Forecast, by Technology, 2021-2034 ($ Mn)
Chapter 7 Market Estimates and Forecast, by Age Group, 2021-2034 ($ Mn)
Chapter 8 Market Estimates and Forecast, by Service Provider, 2021-2034 ($ Mn)
Chapter 9 Market Estimates and Forecast, by Region, 2021-2034 ($ Mn)
Chapter 10 Company Profiles
Companies Mentioned
The companies featured in this Surrogacy market report include:- IVIRMA
- Bangkok IVF Center
- Boston IVF
- Bourn Hall International (TVM Capital Healthcare)
- Circle Surrogacy
- Extraordinary Conceptions
- Growing Generations
- Houston Fertility Center
- Kindbody
- Max Healthcare
- MLSPL (Morpheus IVF Clinic)
- New Hope Fertility Clinic
- NOVA IVF
- Ovation Fertility
- Scanfert Clinic
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 133 |
| Published | April 2025 |
| Forecast Period | 2024 - 2034 |
| Estimated Market Value ( USD | $ 22.4 Billion |
| Forecasted Market Value ( USD | $ 201.8 Billion |
| Compound Annual Growth Rate | 24.6% |
| Regions Covered | Global |
| No. of Companies Mentioned | 16 |
